Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barohn

Showing results (241-250 of 345) with videos related to

Pageof 35
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2015
Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALSRobert G Miller, Gilbert Block, Jonathan S Katz, et al.
Journal of the Neurological Sciences|October 26, 2001
A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patientsC E Jackson, J Rosenfeld, D H Moore, et al.
Brain : a Journal of Neurology|March 1, 2014
Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlationTracey D Graves, Yoon-Hee Cha, Angelika F Hahn, et al.
Annals of Neurology|February 1, 1996
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupR G Miller, J H Petajan, W W Bryan, et al.
Neurology|May 11, 2005
Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutationsP M Grogan, S M Tanner, K H Ørstavik, et al.
Brain : a Journal of Neurology|November 18, 2009
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatmentE Matthews, D Fialho, S V Tan, et al.
Archives of Neurology|May 18, 1999
Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristicsG I Wolfe, N S Baker, A A Amato, et al.
Neurology|September 25, 2003
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of NeurologyR A C Hughes, E F M Wijdicks, R Barohn, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|May 15, 2003
Can we eliminate placebo in ALS clinical trials?W W Bryan, R J Hoagland, J Murphy, et al.
Neuromuscular Disorders : NMD|May 30, 2015
Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patientsNicholas E Johnson, W David Arnold, Donald Hebert, et al.
Pageof 35

Showing results (241-250 of 345) with videos related to

Sort By:
Pageof 35
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2015
Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALSRobert G Miller, Gilbert Block, Jonathan S Katz, et al.
Journal of the Neurological Sciences|October 26, 2001
A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patientsC E Jackson, J Rosenfeld, D H Moore, et al.
Brain : a Journal of Neurology|March 1, 2014
Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlationTracey D Graves, Yoon-Hee Cha, Angelika F Hahn, et al.
Annals of Neurology|February 1, 1996
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupR G Miller, J H Petajan, W W Bryan, et al.
Neurology|May 11, 2005
Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutationsP M Grogan, S M Tanner, K H Ørstavik, et al.
Brain : a Journal of Neurology|November 18, 2009
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatmentE Matthews, D Fialho, S V Tan, et al.
Archives of Neurology|May 18, 1999
Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristicsG I Wolfe, N S Baker, A A Amato, et al.
Neurology|September 25, 2003
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of NeurologyR A C Hughes, E F M Wijdicks, R Barohn, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|May 15, 2003
Can we eliminate placebo in ALS clinical trials?W W Bryan, R J Hoagland, J Murphy, et al.
Neuromuscular Disorders : NMD|May 30, 2015
Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patientsNicholas E Johnson, W David Arnold, Donald Hebert, et al.
Pageof 35